PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2024. Start Trial.
Date Value
November 18, 2026 2.105
November 17, 2026 1.928
November 16, 2026 2.152
November 13, 2026 2.203
November 12, 2026 2.315
November 11, 2026 2.397
November 10, 2026 2.376
November 09, 2026 2.39
November 06, 2026 2.254
November 05, 2026 2.886
November 04, 2026 2.947
November 03, 2026 2.791
November 02, 2026 2.947
October 30, 2026 2.838
October 29, 2026 2.831
October 28, 2026 2.892
October 27, 2026 2.797
October 26, 2026 2.872
October 23, 2026 2.831
October 22, 2026 2.818
October 21, 2026 2.967
October 20, 2026 2.852
October 19, 2026 2.763
October 16, 2026 2.777
October 15, 2026 2.804
Date Value
October 14, 2026 2.709
October 13, 2026 2.852
October 12, 2026 2.920
October 09, 2026 2.845
October 08, 2026 2.801
October 07, 2026 2.845
October 06, 2026 2.899
October 05, 2026 2.872
October 02, 2026 2.852
October 01, 2026 2.933
September 30, 2026 3.035
September 29, 2026 2.598
September 28, 2026 2.593
September 25, 2026 2.696
September 24, 2026 2.627
September 23, 2026 2.713
September 22, 2026 2.444
September 21, 2026 2.427
September 18, 2026 2.375
September 17, 2026 2.450
September 16, 2026 2.329
September 15, 2026 2.335
September 14, 2026 2.352
September 11, 2026 2.346
September 10, 2026 2.381

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Théraclion SA 29.86
Koninklijke Philips NV 1.381
Accuray, Inc. 0.0174
Medtronic Plc 3.452
Orthofix Medical, Inc. 0.3079

PS Ratio Related Metrics

PEG Ratio -0.0518
Price to Book Value 3.692
Price 2.81
Earnings Yield -17.44%
Market Cap 132.69M
PEGY Ratio -0.0518